ADCT icon

ADC Therapeutics
ADCT

Overview Fund Activity

60 hedge funds and large institutions have $149M invested in ADC Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-6
Holders Change %
-9.09%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
19
Reduced
13
Closed
22
Calls
$21K
Puts
$40K
Net Calls
-$19K
Net Calls Change
+$147K

Top Buyers

1
Millennium Management
Millennium Management
New York
$13.1M
2
Goldman Sachs
Goldman Sachs
New York
$8.3M
3
Citadel Advisors
Citadel Advisors
Florida
$7.63M
4
Bank of America
Bank of America
North Carolina
$6.16M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$2.71M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$17.9M
2
DM
Deerfield Management
New York
$0
3
HA
HHLR Advisors
Cayman Islands
$0
4
American Century Companies
American Century Companies
Missouri
$0
5
MCMC
Matrix Capital Management Company
New Hampshire
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CF
76
CNA Financial
Illinois
– -$67K -13,945 Closed
CCG
77
Cypress Capital Group
Florida
– -$48K -10,000 Closed
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
– -$3.5K -726 Closed
Wells Fargo
79
Wells Fargo
California
– -$1K -200 Closed
1 2 3
4